Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
BMC Cancer
; 15: 255, 2015 Apr 11.
Article
in En
| MEDLINE
| ID: mdl-25886314
Full text:
1
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Glioblastoma
/
Sirolimus
/
Antibodies, Monoclonal, Humanized
Limits:
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2015
Type:
Article
Affiliation country:
Singapore